Ignite Creation Date:
2024-10-25 @ 8:05 PM
Last Modification Date:
2024-10-26 @ 3:43 PM
Study NCT ID:
NCT06657157
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-10-19
Brief Title:
Peripheral Neuropathy in Patients Receiving Enfortumab Vedotin and Pembrolizumab As First Line Treatment for Metastatic or Locally Advanced Urothelial Carcinoma
Sponsor:
Organization:
None